Esophageal – EA2174

Protocol
EA2174

Sponsor
ECOG-A

Title
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

For More Information:
Click Here

<< Back to Trials